Squarepoint
TNDM icon

Squarepoint’s Tandem Diabetes Care TNDM Stock Holding History

Squarepoint’s Portfolio TNDM Stock Details TNDM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-6,500
Closed -$234K – 5417
2024
Q4 		$234K Buy
+6,500
New +$220K ﹤0.01% 4350
2023
Q2 		– Sell
-14,000
Closed -$569K – 4017
2023
Q1 		$569K Sell
14,000
-10,900
-44% -$451K ﹤0.01% 2229
2022
Q4 		$1.12M Buy
+24,900
New +$1.13M ﹤0.01% 1746
2022
Q3 		– Sell
-29,700
Closed -$1.76M – 3441
2022
Q2 		$1.76M Buy
+29,700
New +$2.44M 0.01% 1280

Other funds holding TNDM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SC
Sessa Capital New York $5.98B AUM 99.85% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $12.8B AUM 48.82% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $627M AUM 43.41% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return

Squarepoint's TNDM Position: Q2 2026 in Review

Squarepoint opened a new position in Tandem Diabetes Care (TNDM) in Q2 2026: 217,386 shares worth $3.28M. The stake represents ﹤0.01% of the portfolio and ranks #1937 among its holdings. This is a return to the name: Squarepoint previously reported a position in TNDM as recently as Q2 2025.

Squarepoint first reported a position in TNDM in Q2 2017 and has held it in 28 quarters since. The position peaked at $21.2M in Q2 2022. 274 funds tracked by Wall St. Rank hold TNDM as of Q2 2026.

  • Squarepoint held 217,386 shares of Tandem Diabetes Care worth $3.28M as of Q2 2026.
  • Tandem Diabetes Care was a new Squarepoint position in Q2 2026.
  • Tandem Diabetes Care made up ﹤0.01% of Squarepoint's portfolio in Q2 2026, its #1937 holding.
  • Squarepoint first reported a position in Tandem Diabetes Care in Q2 2017 and has held it in 28 quarters since.
  • Squarepoint's Tandem Diabetes Care position peaked at $21.2M in Q2 2022.
  • 274 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q2 2026.

Based on Squarepoint's 13F filing for Q2 2026, filed 14 Aug 2026.